Sphingosine-1-phosphate lyase (SPL), a key enzyme of sphingolipid metabolism, catalyzes the irreversible degradation of sphingoid base phosphates. Its main substrate sphingosine-1-phosphate (S1P) acts both extracellularly, by binding G protein-coupled receptors of the lysophospholipid receptor family, and inside the cell, as a second messenger. There, S1P takes part in regulating various cellular processes and its levels are tightly regulated. SPL is a pivotal enzyme regulating S1P intracellular concentrations and a promising drug target for the design of immunosuppressants. We structurally and functionally characterized yeast SPL (Dpl1p) and its first prokaryotic homolog, from Symbiobacterium thermophilum. The Dpl1p structure served as a basis for a very reliable model of Homo sapiens SPL. The above results, together with in vitro and in vivo studies of SPL mutants, reveal which residues are involved in activity and substrate binding and pave the way to studies aimed at controlling the activity of this pivotal enzyme.
INTRODUCTION
Sphingolipids are ubiquitous constituents of cell membranes and their metabolites play the role of signaling molecules in eukaryotic cells (Hannun and Obeid, 2008) . A very important sphingolipid is sphingosine-1-phosphate (S1P), which acts as a second messenger and takes part in the regulation of cell proliferation, motility, invasiveness, and apoptosis (Hait et al., 2009; Spiegel and Milstien, 2003) . The effects of S1P have been described in a wide spectrum of organisms, ranging from Arabidopsis thaliana (Dunn et al., 2004; Pata et al., 2009; Tsegaye et al., 2007) , Saccharomyces cerevisiae to Caenorhabditis elegans (Oskouian and Saba, 2004) , Mus musculus (Forrest et al., 2004) , and Homo sapiens (Oskeritzian et al., 2007; Rivera et al., 2008; Saba and Hla, 2004) . S1P is unique in that it can act both as an intracellular second messenger (Hait et al., 2009 ) and as a ligand for G protein-coupled cell-surface receptors belonging to the lysophospholipid receptor family (Hla et al., 2001 ; Takabe et al., 2008) .
The intracellular levels of S1P are kept under tight control by three enzymes, the first of which, sphingosine kinase, catalyzes S1P synthesis, while the other two, sphingosine-1-phosphate phosphatase and sphingosine-1-phosphate lyase (SPL, EC 4.1.2.27), catabolize it. While sphingosine-1-phosphate phosphatase catalyzes the reversible dephosphorylation of S1P, SPL degrades it irreversibly to phosphoethanolamine (PE) and hexadecenal . This complex regulation of S1P levels is biologically very significant in light of the so-called ''sphingolipid rheostat,'' whereby cell fate depends on the ratio of intracellular S1P, which is a proliferative stimulus, and sphingosine and ceramide, which induce apoptosis (Spiegel and Milstien, 2003) .
Notably, SPL was found to play an important role in regulating the immune system. Schwab and Cyster (2007) and Schwab et al. (2005) showed that 2-acetyl-4-tetrahydroxybutylimidazole (THI), a component of the food colorant caramel III, inhibits SPL, which normally maintains a steep S1P concentration gradient between the lymphoid tissues and the vascular circulation. T cells egress from lymphoid tissues by navigating along the S1P gradient. SPL inhibition by THI leads to disruption of the S1P gradient, thus preventing the egress of T cells into the blood stream and causing a logjam in lymphoid tissues (Schwab and Cyster, 2007; Schwab et al., 2005) . There is also evidence of SPL involvement in tumor-suppressor and cancer surveillance pathways (Oskouian et al., 2006) and resistance to cisplatin. Control of SPL expression and activity may prove useful in the future in adjuvant and reproductive cell-protecting approaches to cancer therapy .
SPL belongs to the superfamily of PLP (pyridoxal 5 0 -phosphate)-dependent enzymes. Its activity was first characterized more than 40 years ago (Stoffel et al., 1968) ; more recently, the genes for C. elegans (Mendel et al., 2003) , yeast (Saba et al., 1997) , mouse (Zhou and Saba, 1998) , plant (Nishikawa et al., 2008) , and human SPL (Van Veldhoven et al., 2000) were cloned. To date, there is scarce data about the structure and biochemistry of SPL. The enzyme is known to be located in the ER (endoplasmic reticulum) and to possess an N-terminal lumenal domain, a transmembrane segment and a soluble PLP-binding domain, responsible for the catalytic activity Van Veldhoven and Mannaerts, 1991) .
The biological relevance and the growing amount of interest around SPL as a drug target Fyrst and Saba, 2008; Han et al., 2009; Kumar and Saba, 2009 ) mandated, as the next step, high-resolution structural characterization of this enzyme, which had to date been shown to exist only in eukaryotes. To this end, we first used a bioinformatically identified putative prokaryotic homolog, the product of gene STH1274 from the commensal thermophilic bacterium Symbiobacterium thermophilum (Ueda et al., 2004 ), which we characterized as a bona fide sphingosine-1-phosphate lyase and named StSPL. This in turn allowed us to solve the structure of Saccharomyces cerevisiae SPL, called Dpl1p, and obtain a reliable homology model of the human counterpart, SPL. Both StSPL and Dpl1p exhibit flexible stretches in regions surrounding the active site. These flexible regions carry crucial residues for activity, as shown by our thorough mutagenesis-based functional analysis. Altogether, our structural and functional studies of StSPL and Dpl1p allowed us to propose a reaction mechanism for the cleavage of long-chain base phosphates by SPL.
RESULTS AND DISCUSSION
Structure of Full-Length StSPL: Symmetries and Asymmetries In a previous study (Mukhopadhyay et al., 2008) , we had described a parsed homology model of the active site of Dpl1p, based on the active site of Escherichia coli glutamate decarboxylase (GadB) (Capitani et al., 2003; Gut et al., 2006) , which shares 23% sequence identity with Dpl1p over a 251 residue stretch. Mutations based on that limited model and assumed to influence the enzyme activity were confirmed by cell biology data (Mukhopadhyay et al., 2008) . As the next step, we embarked on a structure determination program, encompassing not only Dpl1p but also a putative prokaryotic SPL homolog in Symbiobacterium thermophilum (Uniprot code Q67PY4), which we had identified by a BLAST search (Altschul et al., 1997) of Dpl1p taxonomically limited to prokaryotes and named StSPL. We cloned the gene encoding Q67PY4 from the genome of S. thermophilum, expressed it in E. coli, and obtained pure protein and diffraction-quality crystals. The structure of StSPL was solved first, with a molecular replacement approach. A dimer from the GadB hexamer was used as the search model. Two StSPL structures were refined at 2.0 and 3.0 Å resolution (Table 1) , respectively, from two different crystal forms, the first (St_1) ( Figure 1A ) containing a symmetric StSPL dimer in the asymmetric unit (a.u.), the second (St_2) (Figure 4 ) also containing one dimer per a.u. but featuring clear conformational asymmetry between subunits A and B. The asymmetry was not only limited to the protein chains but involved cofactor binding as well. While in St_1 both active sites contain a PLP molecule covalently bound to K311 to form an internal aldimine, in St_2 one active site is PLP-free and contains a phosphate ion at the place of the cofactor phosphate moiety ( Figure 4B ). The following structural description of the StSPL structure refers to St_1 (Figure 2A ): each subunit can be divided into a N-terminal disordered region (called hereafter Nt-FLEX), spanning residues 1-57 and corresponding to absent or poor electron density, and a folded core encompassing residues 58-507. The core exhibits a typical type 1 PLP-dependent enzyme fold, attributed by the SCOP database (Andreeva et al., 2008) to the pyridoxal-dependent decarboxylases subfamily. Its closest structural relative is GadB, with a rmsd of 2.2 Å over 363 common C a atoms. The StSPL core can be divided into an N-terminal domain (residues 58-97), a large domain containing the cofactor binding K311 (residues 98-382) and a small C-terminal domain (residues 383-471). This domain structure is common with pyridoxaldependent decarboxylases like GadB. StSPL, however, possesses a fourth C-terminal domain, dubbed C-terminal extension (Ct-EXT, residues 472-507).
Structure of Dpl1p D1-102: Similarities and Differences to StSPL Using the structure of the K311A StSPL mutant (Bourquin, 2010) (at the time it was the highest quality structure of StSPL available) as search model, we could solve and refine the structure of Dpl1p D1-102 at 3.15 Å resolution (Table 1 ) (space group F222, with two Dpl1p D1-102 subunits per a.u., creating two different dimers by crystallographic symmetry). The use of a highresolution, well-refined model of StSPL was instrumental to locating the two Dpl1p D1-102 subunits with Phaser (McCoy, 2007) . The solution found refined well in Phenix (Zwart et al., 2008) . The two refined Dpl1p D1-102 dimers are conformationally very similar but differ by cofactor binding, since one of them (Dpl1p-S) contains PLP in both active sites ( Figure 1B ), while the other (Dpl1p-A, mainly apo) exhibits very low occupancy of the cofactor (not modeled) ( Figure 3A ). As in subunit B of St_2 ( Figure 4B ), the missing cofactor is partly replaced by a phosphate ion. The overall structure of Dpl1p D1-102 is very similar to that of StSPL, with a rmsd between the Dpl1p-S and St_1 dimers of 1.2 Å over 399 common C a atoms ( Figure 3B ) and of 1.2 Å over 396 common C a atoms between the Dpl1p-A and St_1 dimers and 42% sequence identity. Notably, even though the Nt-FLEX of StSPL and Dpl1p differ substantially, with the latter containing a predicted lumenal domain, followed by a transmembrane region and a cytoplasmic spacer ( Figure 7A ), their end is spatially very well conserved: the observed folded core of Dpl1p D1-102 starts with residue N131, superimposing well onto residue K58 of St_1 ( Figure 3B ). The same degree of conservation is observed also with respect to the domain structure. In the folded core of Dpl1p D1-102, the N-terminal domain spans residues 131-167, the large domain containing the cofactor-binding K380 extends from 168 to 451, the small domain from 452 to 540 and the Ct-EXT from 541 to 589 (Figure 2B) . The only significant structural difference between St_1 and Dpl1p D1-102 resides in Ct-EXT, where Dpl1p-S residues 541 to 563 (566 in Dpl1p-A) and 580 to 589 are conformationally disordered and correspond to absent or very poor electron density (Figures 1B, 2B, 2D, and 3) . This difference appears to have important functional implications as Dpl1p D1-102 was found to be inactive in vitro (see section on activity and mutagenesis studies) even though its boundaries correspond perfectly to those of the folded core of StSPL ( Figure 3B ), which is active in vitro. Since full-length (FL) Dpl1p is active in vivo ( Figure 7B ), we assume that Nt-FLEX (residues 1-130) plays a key role for activity, presumably in substrate presentation to the active site, and the absence of its first 102 residues may be correlated with the disorder of Ct-EXT. This is corroborated by the observation that in StSPL residues 473-488 constitute the ''bottom wall'' of a long hydrophobic pocket adjacent to the active site, which is not present in GadB and most likely accommodates the long hydrophobic chain of the substrate before its entrance into the active site ( Figure 2C ). In the crystal structure of Dpl1p D1-102 the aforementioned hydrophobic pocket lacks the ''bottom wall'' ( Figure 2D ) since residues 541-563 are disordered.
The Region around the Active Site in StSPL: More Asymmetries and Comparison to Other Enzymes As mentioned above, the St_2 structure of FL WT (wild-type) StSPL exhibits clear asymmetries between subunits A and B, in contrast to the symmetry shown by the St_1 dimer. The 
Structure
Pro-and Eukaryotic Sphingosine-1-Phosphate Lyase asymmetries of St_2 are not limited to the lack of PLP in subunit B but involve the protein conformation around the active site ( Figure 4 ): while in subunit A the regions surrounding the active site are ordered and a chloride ion is found at the position occupied by a phosphate ion in St_1 (Figure 2A ), in subunit B no chloride or phosphate ion is observed and the loop comprising residues 90-107 is mostly disordered, with only residues G102 to Y105 corresponding to interpretable density ( Figure 4B ). The Ct-EXT of subunit A is again partly disordered, with only residues 475-483 and 490-507 corresponding to interpretable density. The entire Ct-EXT of subunit B is disordered. As a consequence, the hydrophobic pocket of subunit B of St_2 partly lacks its ''bottom wall'' ( Figure 2C ), while its counterpart in subunit A is nearly complete since its Ct-EXT is partly ordered. Yet another element of asymmetry in St_2 is the S123*-S135* loop (residues followed by an asterisk belong to the neighboring subunit), exhibiting markedly higher B-factors in chain A (lining the active site of subunit B) than in chain B (<B > = 60 Å 2 in the former versus 41 Å 2 in the latter). Crystallographic and biochemical studies of the two isoforms of human glutamate decarboxylase, GAD65 and GAD67 (Fenalti et al., 2007) , showed the importance of a ''catalytic loop'' (residues 432*-442* in GAD67) being ordered or disordered for the control of enzyme activity. The active site loop of human GAD is not conserved in SPL, where it is replaced by a b-hairpin (residues 334*-349* in StSPL) (Figure 2A ), but it suggests a functional role for the aforementioned asymmetric elements of St_2, all of which are located nearby.
Another enzyme involved in sphingolipid metabolism, serine palmitoyl-transferase (SPT), exhibits peculiar asymmetry with respect to PLP binding: it is a heterodimer composed of two strictly related subunits plus a third subunit conferring substrate specificity (Han et al., 2009; Hornemann et al., 2009) . One of the two subunits of the heterodimer lacks the residues for PLP binding even though it is required for activity, as modeled from the structures of Sphingomonas paucimobilis (Yard et al., 2007) and Sphingobacterium multivorum ) SPTs. St_2 features asymmetry in cofactor binding in spite of being a homodimer. Modulation of cofactor binding thus appears to be a feature common to several eukaryotic PLP-dependent enzymes.
Altogether, our structural studies of StSPL and Dpl1p D1-102 reveal that both proteins share the same fold and that the disorder in the N terminus (Nt-FLEX domain) is a conserved feature. Moreover, variations are found in the cofactor occupancy in some forms of both enzymes. One significant difference between StSPL and Dpl1p D1-102 is that the latter lacks part of Ct-EXT covering the active site. Asymmetries between both subunits of one crystal form of StSPL were mapped in three regions surrounding the active site. We assumed that this flexibility is functionally relevant and performed mutagenesis studies of residues carried by these loops (see below).
Cofactor Binding Mode and Active Site in FL StSPL and Dpl1p D1-102 and Model of Substrate Accommodation The cofactor binding mode and the active site in general are very well conserved between StSPL and Dpl1p: in both cases the phosphate moiety of PLP is held in place by a classical ''phosphate cup'' motif (Denesyuk et al., 2003) with residues Structure Pro-and Eukaryotic Sphingosine-1-Phosphate Lyase (StSPL numbering) G168, T169, H310, and S353* hydrogenbonding the phosphate oxygen atoms (see Figures S1A and B available online). The pyridinium ring of PLP is sandwiched between residues C276 and H201 in StSPL, corresponding to residues C344 and H268 in Dpl1p. Another common feature is a phosphate ion found at the same position in both proteins, in the vicinity of the cofactor. The ion interacts with the phenolic moiety of Y105, the imidazolium ring of H129*, the main chain amide nitrogen of A103 and the carboxamide group of N126* (distances 2.6, 2.7, 2.8, and 3.2 Å , respectively, in subunit A of St_1). The corresponding phosphate-binding residues in the active site of Dpl1p are Y174, H198*, and A172. The conserved binding mode of the phosphate ion mimics the binding mode of the phosphate moiety of the natural substrate of the enzyme, S1P. This is confirmed by the structure of StSPL K311A in complex with the product PE at 2.9 Å resolution (structure St_3) (Table 1; Figure 5A ). PE is one of the two products of the SPL reaction and contains the polar part of the substrate. No Figure 1 . Additionally, structural elements exhibiting asymmetry between the two subunits of St_2 are depicted as follows: residues A89-D108 in brown, P472-V507 (Ct-EXT) in blue, and K58-F64 in green. The chloride ion bound in the active site of subunit A is shown in beige in space-fill model. The loop S123*-S135*, which completes the active site environment, is colored according to its B-factors (blue corresponds to lower B-factors). significant conformational changes were observed between St_1 and St_3 (rmsd value of 0.3 Å over 446 common C a atoms). PE was seen to form a Schiff base with PLP and its phosphate group replaced the phosphate ion found in the active sites of St_1 and Dpl1p D1-102 (Figures 2A and 2B ). Based on St_3, we modeled the substrate S1P bound in WT StSPL ( Figure S1C ) and carried out mutagenesis studies on residues A103, Y105, H129*, C276, K311, K317, and Y482 ( Figure 5B ). The mutants were designed on the basis of the well-described biochemistry of PLP-dependent enzymes (Eliot and Kirsch, 2004; Toney, 2005) as well as by taking into account the mechanism proposed in Van Veldhoven and Mannaerts (1993) and by assuming that residues found in flexible stretches of Dpl1p D1-102 and St_2 ( Figures 2B and 2D , and Figure 4 , respectively) might be involved in activity (see previous sections). Residues A103 and Y105 (StSPL numbering) are located on the activesite flanking loop that is disordered in subunit B of St_2 (Figure 4 , dark brown loop). H129* and K317 sit near the phosphate moiety of the active site-bound substrate, even though K317 is too distant (nearly 5 Å ) to hydrogen-bond the phosphate. In an early study of SPL (Van Veldhoven et al., 2000) , the residue corresponding to C276 had been proposed to be the nucleophile required for bond cleavage and was therefore included into our mutagenesis study. The activity of mutants of the corresponding residues in Dpl1p (A172, Y174, H198*, C344, K380, K386, and Figure 1A . Figure 4 . The residues studied by mutagenesis are labeled. The model, based on the structure of St_3, is to be considered tentative, especially with respect to the C2-C3 (see Figure 8 , step II) torsion angle and to the conformation of the hydrophobic chain. The optimal conformation for retro-aldol cleavage is with the C3-hydroxyl moiety of S1P antiperiplanar to the amino group of the aldimine (Dunathan, 1966) . In our modeling attempt, such a conformation led to steric clashes with Y249 ( Figure S1C ). (C) Stereo representation of a superposition of Dpl1p D1-102 (Dpl1p-S) onto FL WT StSPL (structure St_1), showing the residues of Dpl1p presumably involved in activity. Color coding is as in Figure 1 . See also Figures S1 and S2.
(B) Same as (A), showing the modeled external aldimine intermediate with S1P (PLP-S1P). Color coding is as in
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Pro-and Eukaryotic Sphingosine-1-Phosphate Lyase Y554) was compared using an in vivo assay (Mukhopadhyay et al., 2008) . The active sites of St_1 and Dpl1p-S superimpose very well and the above-mentioned residues occupy structurally equivalent positions in both enzymes, except for Y554 (Y482 in StSPL), which is found in the disordered region of Ct-EXT of Dpl1p ( Figure 5C ).
Importantly, Dpl1p D1-102 shares 45% sequence identity over 420 residues with its medically important human counterpart, SPL (UniProt code O95470): we could calculate a reliable homology model of SPL ( Figure S1D) , showing that the active site is conserved between the two proteins, with the exception of T148 in SPL (A172 in Dpl1p). A multiple sequence alignment of StSPL, Dpl1p and SPL with the predicted secondary structure elements can be found in Figure S2 . The structural features and the functionally important residues described in this study provide a solid basis for future mutagenesis and inhibition studies of SPL.
Activity and Mutagenesis Studies of StSPL and Dpl1p
The visible spectrum of FL WT StSPL exhibits a shoulder at 340 nm and a broad peak at 420-460 nm, presumably resulting from the contribution of two species centered at 425 and 450 nm ( Figure 6A species. The spectra of mutants K311A and C276A ( Figures 6B and 6E , dotted lines) and of construct DCt-EXT (lacking residues 472-507) ( Figure S3B , dotted lines) differ markedly from that of FL WT. They feature a peak at 345 nm, which may correspond to the hydrated form of PLP, as seen in the structure of StSPL K311A (Bourquin, 2010) .
Mutagenesis studies were carried out on the residues listed above as well as on Nt-FLEX and Ct-EXT truncation variants of StSPL (Figure 2A ). There are many SPL activity assays available, based on the detection of fluorescent species (Bedia et al., 2009; Bandhuvula et al., , 2009 . In the present work, the activity of StSPL mutants and variants compared with FL WT was assessed by spectrophotometry and mass spectrometry (MS). The first method monitors variations occurring in the environment of PLP upon catalysis, as shown for serine palmitoyltransferase Raman et al., 2009; Shiraiwa et al., 2009) , and thereby indirectly monitors the activity of the protein, while the latter monitors substrate cleavage. Both tests provided qualitative information. Quantitative analysis was hindered by variations in the amount of soluble material, presumably due to discrepancies in the purity of S1P from various batches of chemical synthesis or of extraction from natural sources, to the inherently poor solubility of S1P (García-Pacios et al., 2009) and to the challenging reproducibility of the solubilization procedure, as well as by variations when desalting the sample before MS. As a consequence, an accurate concentration of S1P was difficult to obtain, resulting in different response intensities in the activity assays. Therefore, the activity of mutants or variants of StSPL has to be compared with that of the FL WT StSPL purified in parallel and tested under similar conditions.
The spectrophotometric activity assay monitors the appearance and disappearance of transient peaks at 403 and 420 nm, accompanied by a decrease in the absorption at 450 nm, that appeared upon mixing FL WT StSPL with S1P (Figures 6A Structure Pro-and Eukaryotic Sphingosine-1-Phosphate Lyase and 6F; Figures S3C and S3G ), dihydrosphingosine-1-phosphate (DHS1P) ( Figure S3H ) or phytosphingosine-1-phosphate (PS1P) ( Figure S3I ). We tentatively interpret those peaks as the external aldimine species PLP-S1P and PLP-PE (Figure 8 , steps III and VII). The 420 nm band may correspond to the external aldimine with PE, since a spectrum of StSPL K311A incubated with PE shows a slowly appearing, broad band centered at about 425-430 nm (Bourquin, 2010) . It is noteworthy that no similar changes were observed upon incubating StSPL WT and PE (Bourquin, 2010) . The above transient spectrophotometric changes correlate with the cleavage of S1P, as shown by MS ( Figures S4C and S4D) . The time elapsed until disappearance of the peaks (relaxation time) is assumed to be proportional to the amount of enzyme and its degree of activity. When FL WT StSPL was incubated with semicarbazide, a general PLP-dependent enzyme inhibitor, the 420-460 nm peak disappeared and was replaced by a 360 nm peak with a clear isosbestic point ( Figure S5C ), and only very faint transient peaks were observed upon substrate addition ( Figure S5D ). The PLP-semicarbazone adduct ( Figure S5B ) formed by the inhibitor with the cofactor was found by crystallography (structure St_4) to have left the active site ( Figure S5A ). This correlates with the observation that cocrystals of StSPL with 10-fold molar excess of semicarbazide are colorless, while the native crystals are bright yellow (Bourquin, 2010) . In St_4, the nearby residue Y249 ( Figure S1C ) partly replaces the pyridinium ring of the PLP but is likely not involved in catalysis, since mutant Y249F behaves similarly as FL WT ( Figures S5E and S5F, respectively) . StSPL mutants K311A and Y105F did not exhibit significant time-dependent changes in the spectrophotometric ( Figures 6B and 6C , respectively) and MS ( Figures S4H and S4I , respectively) assays and were categorized as inactive. Mutants A103P and K317A ( Figures S3E and S3F , respectively) exhibited no transient peaks at 403 and 420 nm and no activity in the MS assay ( Figure S4J and S4K, respectively). All the above mutants were categorized as inactive. StSPL Y482F, C276A ( Figures 6D and 6E , respectively), H129A and DCt-EXT ( Figures S3D and S3B , respectively) exhibited a significantly longer relaxation time and much less intense transient peaks (especially for H129A) and were thus assumed to be partly active. StSPL DNt-FLEX behaved similarly (albeit with an altered relaxation time) as FL WT ( Figure S3A ). The Dpl1p truncation D1-102 used for structure determination did not exhibit any visible spectrum alterations upon addition of S1P, DHS1P nor PS1P ( Figures S3J, S3K , and S3L, respectively) and was therefore considered as inactive in vitro.
The Nt-FLEX of FL Dpl1p (residues 1-130) is assumed to consist, from its N to C terminus, of a lumenal domain (residues 1-57), a transmembrane helix (residues 58-82), a linker and a spacer ( Figure 7A) . A yeast synthetic lethality test (Mukhopadhyay et al., 2008) was used to assess the activity of mutants and of the lumenal domain truncation of Dpl1p. Dpl1p D1-57 and FL Dpl1p Y174F, H198A, Y554F are partly active, C344A is probably slightly less active as the WT, while K380A, A172P, and K386A are inactive ( Figure 7B ). The mutagenesis results of Dpl1p are in good agreement with those of StSPL, except for Y174F (corresponding to StSPL Y105F). This single difference might arise from the very different time scale of the in vitro experiments compared with the in vivo experiments or from other sources of bias. For instance, we do not know which enzymatic parameters (K m , K cat ) are most crucial for the in vivo experiment. Alternatively, the precise role of this residue might not be conserved between StSPL and Dpl1p, as a result of different modes of regulation. Importantly, Y174 of Dpl1p is conserved in SPL (Y150). Dpl1p Y174F was found to be partly active: a possible role for this residue is that of influencing the protonation state of K386 and this might represent a regulation mechanism of eukaryotic SPLs.
Further analysis is required to confirm that StSPL Y105F is fully inactive since our in vitro assays are not quantitative. Based on Figure 1B . TMH, transmembrane helix. (B) Yeast strain RH4863 carrying FL WT Dpl1p, Dpl1p D1-57, FL mutants A172P, Y174F, H198A, C344A, K380A, K386A, and Y554F or an empty vector (designated dpl1pD) were 5-fold serially diluted and spotted onto SD plates without leucine or on SD plates with uracil and 5-fluoroorotic acid (5-FOA). Only strains carrying a functional Dpl1p can grow in presence of 5-FOA (Mukhopadhyay et al., 2008) . The colonies were photographed after 3 days of incubation at 30 C.
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Pro-and Eukaryotic Sphingosine-1-Phosphate Lyase our model ( Figure 5B ) residues (StSPL numbering) Y105 and H129*, found close to the phosphate head of the substrate, are important for substrate binding. The side-chain amino group of K317 is also close to the phosphate location but not within hydrogen-bonding distance (4.8 Å in St_1, subunit A). A103 appears to keep the loop 89-108, containing Y105 ( Figure 4A , dark brown), in a conformation able to bind the phosphate moiety of the cofactor. The corresponding residue of SPL, T148, might provide additional stabilization by interacting with H174* and N171* ( Figure S1D ). Figure 8 summarizes the reaction mechanism we propose based on the structural, biochemical and literature information available.
Step III is a retro-aldol cleavage whereby a base (depicted as B:) nucleophilically attacks the proton of the hydroxyl moiety of the substrate. Based on our current model of the external aldimine with S1P ( Figure 5B ) the identity of that base is not clear and its elucidation will require further structural and biochemical studies. Notably, for serine hydroxymethyltransferase, another PLP-dependent enzyme catalyzing a retro-aldol cleavage, finding the corresponding base has proved similarly difficult (Schirch and Szebenyi, 2005) . The quinonoid reprotonation step (step VI), resulting in the formation of the external aldimine PE-PLP and in the subsequent release of PE (steps VII and VIII, respectively) may be carried out by StSPL K311 or by the nearby Y105 (K380 and Y174 in Dpl1p, K353 and Y150 in SPL) . K317 of StSPL (K386 in Dpl1p and K359 in SPL) for sure electrostatically contributes to the binding of the phosphate moiety of the substrate and may also play an indirect role in the reprotonation. The partial activity of the alanine mutant of C276 (C344 and C317), a PLP stacking residue, indicates that its role is mostly structural, keeping the cofactor in an optimal position for reactivity. This is consistent with the observation that the side chain thiol of C276 points away from the substrate instead of toward it. Y482 (Y554 and Y526) appears to play an important role in activity, possibly in substrate accommodation since it belongs to the ''bottom wall'' region discussed above. Further analysis is required to decipher the precise role of all residues involved in the reaction mechanism of SPL.
As mentioned above, the extent of disorder or flexibility of the N termini (Nt-FLEX) seems to be conserved from StSPL to Dpl1p D1-102 ( Figure 3B ) and may reflect a functional role, presumably in accommodating the substrate embedded in The incoming S1P (step II) replaces the catalytic lysine (311 in StSPL and 380 in Dpl1p) as Schiff base partner of PLP, forming an external aldimine (step III). Retroaldol cleavage occurs at the hydroxyl group of carbon atom 3 of S1P (step III) and the long-chain aldehyde product (called hexadecenal in case S1P is the substrate) is released (step IV). The second external aldimine (step VII) results from reprotonation (step VI) of the quinonoid intermediate (step V). PE is then released (step VIII) and the internal aldimine is re-formed (step I): the enzyme is now ready for a second turnover. the membrane. Since StSPL lacks a transmembrane helix, the precise mechanism of accommodation is most probably not conserved, because StSPL DNt-FLEX behaves as FL WT in the in vitro activity test ( Figure S3A ), and Dpl1p D1-102 is inactive in vitro, while Dpl1p D1-57 is only partly active in vivo ( Figure 7B ).
The N and C termini of StSPL, and most probably of Dpl1p, surround the active site entry channel ( Figures 2C and 2D , respectively) and might act as a gate that isolates the substrate-bound active site from solvent and thus promotes catalysis. Indeed, StSPL DCt-EXT appears to be less active than FL WT StSPL ( Figure S3B ).
Our functional analysis of StSPL and Dpl1p clearly indicates that the flexible regions described in the first sections carry residues crucial for activity. Our results allow a better understanding of the mode of action of this very important enzyme. Given the similarity of the active sites and the high degree of conservation between StSPL, Dpl1p and SPL (Figures 5C, S1 and S2), the proposed mechanism can serve as basis for further studies on the human counterpart.
In conclusion, this study provides the first structural characterization of a eukaryotic SPL, identifies critical residues for activity, sheds light on the reaction mechanism, and demonstrates the existence and functionality of a prokaryotic homolog of the enzyme. Modulating the cofactor occupancy seems to be a common feature of both StSPL and Dpl1p. Moreover, our results allowed the generation of a high-quality homology model of the human enzyme, pinpointing the conservation of the above described residues. Most importantly, they provide a solid foundation for structure-based drug design on SPL.
EXPERIMENTAL PROCEDURES Chemicals
All chemicals and reagents were of the highest commercially available grade.
Plasmid Constructs and Protein Expression and Purification
Plasmid construction and expression and purification of StSPL and Dpl1p D1-102 are described in Supplemental Information.
Activity Assays UV-visible spectra were recorded on a Cary-50 spectrophotometer (Varian) using 1 cm light path quartz precision cells (Hellma). Protein concentration was estimated using an average value of the extinction coefficient of a fully reduced and a fully oxidized protein as calculated with ProtParam (Gasteiger et al., 2005 Biochemicals or Avanti Polar Lipids, while DHS1P and PS1P were from Avanti Polar Lipids. The phosphosphingolipids were solubilized in 1% (w/v) Triton X-100 (Fluka or Acros) to 1 mg/ml (corresponding to 2.6 mM). The suspension was incubated at 37 C for 30 min with 1 min vortexing every 4 min. After 10 min sonification and further vortexing, insoluble material was separated by a 10 min centrifugation step at 14,000 3 g at room temperature. Protein concentration in the cell was set at 22 mM (1.2 mg/ml), for a total volume of 100 ml. Seventy microliters of phosphosphingolipid solution was added to the protein and briefly homogenized with a pipette. The buffer corresponded to the SEC buffer containing 1 mM KPi. Spectra were recorded every minute from 500 to 320 nm until no or only slight spectral changes could be observed. The yeast synthetic lethality test was carried out as described in Mukhopadhyay et al. (2008) .
Semicarbazide (Fluka) was mixed to FL WT StSPL set at 14 mM to a molar excess of 100-fold over active sites and spectra were recorded as described above. After 1 hr incubation, S1P was added and the spectra recorded as described above.
For MS activity assay, S1P cleavage by StSPL was carried out under the same conditions as the spectrophotometric activity assay except that S1P was solubilized in 100% ethanol. The reaction mixture was desalted using C 18 ZipTipÒ pipettes tips (Millipore) and diluted in 50% acetonitrile, 0.2% formic acid (pH 2) before injection. Masses were measured in the positive mode on a quadrupole mass spectrometer equipped with an electrospray (ESI) ionization source and a time of flight (TOF) ion separation device (Q-TOF Ultima API, Waters Corporation). Multiple-charged protein ion signals were deconvoluted to produce zerocharge spectra using the Maximum EntropyTM 1 (MaxEnt1) algorithm in the Micromass MassLynx software package (Thermo Scientific).
Protein Crystallization and Structure Determination Native StSPL and Dpl1p were crystallized by vapor diffusion (sitting drop) at 20 C. For cocrystallization with PE, StSPL K311A (7 mg/ml) was incubated for 10 min on ice with an equimolar amount of PLP. StSPL K311A and PE (Fluka) at a 10-fold molar excess over protein subunit were then incubated overnight at 4 C and concentrated prior to crystallization. Bright yellow (structures St_1, St_2 and Dpl1p), pale yellow (structure St_3) or colorless (structure St_4) crystals appeared after 2-15 days. Crystallization conditions are listed in Table S2 . Crystals were cryoprotected by adding ethylene glycol (EG) to the well solution (which, in cocrystallization experiments, was supplemented with the corresponding compound at the appropriate concentration) (Table S2 ). Crystals were flash-frozen by rapid immersion in liquid propane. Data sets were collected at 100K at the X06SA beamline of the Swiss Light Source (SLS; Villigen, Switzerland). Data were processed with XDS (Kabsch, 1993) . The first structure of StSPL (code St_2) was solved by molecular replacement with Phaser (McCoy, 2007) using a polyserine dimer of GadB (PDB entry 2DGK) as search model. FL WT StSPL set at 3 mg/ml was cocrystallized with semicarbazide according to the same procedure as for PE omitting the initial incubation with PLP and with 45 min incubation at 4 C prior to crystallization.
Crystallographic Refinement and Validation
Refinement was carried out with CNS (Brü nger et al., 1998) and Phenix (Zwart et al., 2008) . The structure of Dpl1p D1-102 was solved with Phaser (McCoy, 2007) using a refined dimeric model of StSPL K311A (Bourquin, 2010) . NCS restraints were employed by default and manually edited during refinement, unless data resolution was high enough to render them superfluous (Table 1) . Models were rebuilt with Coot (Emsley and Cowtan, 2004) and validated with ProCheck (Laskowski et al., 1993) and MolProbity (Davis et al., 2007) . PDB entry codes are 3MAD (St_1), 3MAF (St_2), 3MAU (St_3), 3MBB (St_4), and 3MC6 (Dpl1p).
Modeling of SPL and of StSPL K311A in Complex with S1P A dimeric homology model of the folded core of SPL was computed based on the structure of Dpl1p D1-102 using the program Modeller 9v6 (Sali, 1995) . The PLP cofactor was also included in the calculation as a rigid-body residue. The model, including the internal aldimine linkage of the cofactor with K353, was geometry minimized with Phenix (Zwart et al., 2008) . A tentative model of StSPL K311A containing the external aldimine intermediate with the substrate S1P was prepared with Coot based on the structure of St_3 ( Figure S1C ). The S1P ligand was obtained from PDB entry 3I9G (Wojciak et al., 2009) , manually coupled with PLP and optimized with the PRODRG server (http://davapc1.bioch.dundee.ac.uk/prodrg/). The S1P hydrophobic chain was positioned such that it interacts with a hydrophobic region encompassing residues L128*, Y249, L344*, Y345*, F346*, V496, L497, and F500. The model was energy-minimized with Phenix. 
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